WITheranostics : WITH platform

WITheranostics : WARS1 targeted -Immune disorder Theranostics

We have successfully developed our proprietary platform technology, known as the WITH platform, an acronym for WARS1 targeted immune disorder theranostics development technology, which provide a significant breakthrough for precision medicine field. Through WARS1 analysis of patient clinical samples and target disease validation, our platform has the capability to accurately identify patients who require specific WARS1 treatment, leading to the development of WARS1 medicine.